Are Plasma Citrulline and Glutamine Biomarkers of Intestinal Absorptive Function in Patients With Short Bowel Syndrome?
Sensitive biomarkers for intestinal absorptive function would be clinically useful in short bowel syndrome (SBS). Citrulline (Cit) is a product of the metabolism of glutamine (Gln) and derived amino acids by enterocytes. Cit is produced almost exclusively by the gut, which is also a major site of Gl...
Saved in:
Published in | JPEN. Journal of parenteral and enteral nutrition Vol. 31; no. 1; pp. 1 - 7 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Silver Spring, MD
SAGE Publications
01.01.2007
ASPEN American Society for Parenteral and Enteral Nutrition |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Sensitive biomarkers for intestinal absorptive function would be clinically
useful in short bowel syndrome (SBS). Citrulline (Cit) is a product of the
metabolism of glutamine (Gln) and derived amino acids by enterocytes. Cit is
produced almost exclusively by the gut, which is also a major site of Gln
metabolism. The goals of this study were to examine whether plasma Cit and Gln
concentrations are biomarkers of residual small intestinal length and nutrient
absorptive functions in adult SBS patients followed prospectively. We studied
24 stable adults with severe SBS receiving chronic parenteral nutrition (PN)
in a double-blind, randomized trial of individualized dietary modification±
recombinant human growth hormone (GH). During a baseline week,
intestinal absorption studies (% absorption of fluid, kcal, nitrogen, fat,
carbohydrate, sodium, phosphorus, and magnesium) were performed and
concomitant plasma Cit and Gln concentrations determined. Individualized
dietary modification and treatment with subcutaneous injection of placebo (n =
9) or GH (0.1 mg/kg daily × 21 days, then 3 times/week; n = 15) were
then begun. PN weaning was initiated after week 4 and continued as tolerated
for 24 weeks. Repeat plasma amino acid determination and nutrient absorption
studies were performed at weeks 4 and 12. Residual small bowel length at
baseline was positively correlated with baseline plasma Cit (r =
0.467; p = .028). However, no significant correlations between
absolute Cit or Gln concentrations and the percent absorption of nutrient
substrates at any time point were observed. Similarly, no correlation between
the change in Cit or GLN concentration and the change in % nutrient absorption
was observed (baseline vs weeks 4 and 12, respectively). By weeks 12
and 24, 7 and 13 subjects were weaned completely from PN, respectively.
However, baseline plasma Cit or Gln did not predict PN weaning at these time
points. We concluded that plasma Cit (but not Gln) concentrations appeared to
be an indicator of small intestinal length in adult SBS. However, neither
plasma Cit nor Gln was a biomarker for intestinal absorptive function in this
cohort of patients with SBS.
In 24 subjects with severe short bowel syndrome, plasma citrulline concentration was positively correlated with the length of residual small intestine. However, serial measures of plasma citrulline or glutamine concentrations were not significantly correlated with concomitant intestinal macronutrient or micronutrient absorption and did not predict parenteral nutrition dependency during a 24-week follow-up. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-News-1 ObjectType-Feature-3 content type line 23 |
ISSN: | 0148-6071 1941-2444 |
DOI: | 10.1177/014860710703100101 |